β-Lactams and β-Lactamase Inhibitors: An Overview.

By K. Bush, P. Bradford. Cold Spring Harbor Perspectives in Medicine, 2016

1,123 citations recorded by the source corpus.

Subfields: Applied Microbiology and Biotechnology, Molecular Medicine, Pharmacology

View Paper: https://www.semanticscholar.org/paper/62d8d6ad00ac8adc5409c04d1e16cc2cd45a3d0a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Applied Microbiology and Biotechnology

1. W. Reygaert
2. P. Bradford
3. K. Bush

In Molecular Medicine

1. W. Reygaert
2. P. Bradford
3. K. Bush
4. P. Nordmann

In Pharmacology

1. W. Reygaert
2. P. Bradford
3. K. Bush

Citations in the corpus

• Epidemiology of β-Lactamase-Producing Pathogens (2020, background): “Structures include penicillin (1), cephalosporin (2), carbapenem (3), and monobactam (4).”
• An overview of the antimicrobial resistance mechanisms of bacteria (2018, background): “Resistance to the β-lactam drugs occurs through three general mechanisms: (1) preventing the interaction between the target PBP and the drug, usually by modifying the ability of the drug to bind to the PBP (this is mediated by alterations to existing PBPs or acquisition of other PBPs; (2) the presen”